NME1-NME2

NME1-NME2 readthrough transcript (NME1-NME2) gene

Gene Information Card

Symbol NME1-NME2
Full Name NME1-NME2 readthrough transcript
Gene Type readthrough transcript (protein-coding)
Chromosomal Location 17q21.33
NCBI Gene ID 654364 ncbi.nlm.nih.gov/gene/654364
Ensembl ID ENSG00000269821
UniProt ID P22392 (NME2) and P15531 (NME1) are the individual proteins; the readthrough product is not separately curated in UniProt
OMIM ID 156490 (NME1) and 156491 (NME2)
HGNC ID HGNC:26719
Aliases NDPK, NDP kinase, nm23-H1/H2 readthrough

Description

NME1-NME2 is a readthrough transcript that spans the NME1 and NME2 genes on chromosome 17q21.33. This transcript produces a fusion protein that combines sequences from both NME1 (nucleoside diphosphate kinase A) and NME2 (nucleoside diphosphate kinase B). The readthrough product is expressed in various tissues and is implicated in cellular energy metabolism, differentiation, and metastasis suppression. The individual NME1 and NME2 proteins are well-characterized metastasis suppressors; the readthrough isoform may have distinct or overlapping functions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neuroblastoma Altered NME1/NME2 expression is associated with tumor progression and metastasis; readthrough transcript may modulate this effect. PMID: 10647931; NCBI Gene
Breast carcinoma Reduced NME1 expression correlates with high metastatic potential; readthrough transcript may influence NME1/NME2 balance. PMID: 10647931; NCBI Gene
Colorectal cancer NME1 and NME2 expression changes linked to tumor stage; readthrough transcript presence noted in some studies. PMID: 10647931; NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 11.2 Medium
Heart 8.5 Medium
Liver 6.3 Low
Kidney 9.1 Medium
Lung 7.8 Medium
Breast 5.4 Low
Colon 6.0 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 12.5 Readthrough transcript detected by RNA-seq
HeLa 10.3 Readthrough transcript detected by RNA-seq
MCF7 7.1 Readthrough transcript detected by RNA-seq
A549 8.9 Readthrough transcript detected by RNA-seq
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G SNV <0.01% Likely benign; no known functional effect
c.123C>T SNV <0.01% Synonymous; no known functional effect
Mutation functional classification

Loss of Function (LOF)

No loss-of-function mutations reported for the readthrough transcript specifically.

Gain of Function (GOF)

No gain-of-function mutations reported for the readthrough transcript specifically.

Dominant Negative (DN)

No dominant-negative mutations reported for the readthrough transcript specifically.

Pathways

Purine metabolism (Reactome: R-HSA-73817)
Pyrimidine metabolism (Reactome: R-HSA-73821)
GTP biosynthesis (Reactome: R-HSA-73843)

Protein Summary

The NME1-NME2 readthrough transcript encodes a fusion protein that combines the N-terminal region of NME1 (nucleoside diphosphate kinase A) with the C-terminal region of NME2 (nucleoside diphosphate kinase B). This protein retains nucleoside diphosphate kinase activity, catalyzing the transfer of phosphate groups between nucleoside diphosphates and triphosphates. It is involved in cellular energy homeostasis, nucleotide metabolism, and may play a role in metastasis suppression. The readthrough isoform is expressed in multiple tissues and cell lines, with highest levels in brain and heart.

Related Products

Product name Cat.No. Species Gene ID
NME1-NME2 Knockout HEK293 Cell Line EDJ-KQ52395 Human 654364 Details Get a Quote
NME1-NME2 Knockout HeLa Cell Line EDJ-KQ60668 Human 654364 Details Get a Quote
NME1-NME2 Knockout A-549 Cell Line EDJ-KQ69142 Human 654364 Details Get a Quote
NME1-NME2 Knockout HCT 116 Cell Line EDJ-KQ77494 Human 654364 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: